3rd Quarter - Report

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Labor-Health and Human Services Apprpriations fiscal years 2010 and 2011. S. 3690, Drug Safety and Accountability Act of 2010 all provisions. Communication with FDA on the judicious use of medically important antimicrobial drugs in food-producing animals, and the Safe Use Initiative. Communications to Agency for Healthcare Research and Quality regarding comparative effectiveness.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ)

Bills named: S. 3690 (111th)

Medicare/Medicaid MMM

Communication with Centers for Medicare and Medicaid Services on hospital outpatient prospective payment system, and the physician fee schedule for calendar year 2011. Communication with CMS and House and Senate funding regarding specialized pharmacy residency programs.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS)

Pharmacy PHA

Communications with Food and Drug Admnistration on Risk Evaluation and Mitigation Strategies, reauthorization of the Prescription Drug User Fee Act, medical product recalls, experimental study of patient information prototypes and patient medication information, drug shortages, and generic drug user fees. Communication with Centers for Medicare and Medicaid Services regarding administration of medication to inpatients within 30 minutes of scheduled dosage time. HR 5389, The Medicare Clinical Pharmacist Practitioner Services Coverage Act of 2010, all provisions.

LobbyistCovered position, as disclosed
JUSTINE COFFEY —
JOSEPH M HILL —
BRIAN M MEYER —
GERALYN TRUJILLO —

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); SENATE

Bills named: H.R. 5389 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.